Skip to main content

Abstract

In the classic sense of carcinogenesis, such as that produced by ionizing radiation or “carcinogenic” hydrocarbons, hormones are probably not carcinogenic. They are either procarcinogens or cocarcinogens. In this sense, they produce more substrate either for initiation or for promotion by other substances, but of themselves they are probably not carcinogens. In the intact organism, the effects of administration of various hormones at crucial periods of the host’s life cycle may result in carcinogenic effects because of profound lifelong changes in endocrine balance that can be induced by a single hormone administration. This latter phenomenon might be referred to as the inducement of unfavorable hormonal imbalance, and this imbalance has a procarcinogenic effect.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A. Lacassagne, Apparition de cancer de la mamelle chez la souris male, soumise des injections de folliculine, C. R. Acad. Sei. Paris 195, 630–632 (1932).

    Google Scholar 

  2. J. Staats, The laboratory mouse, in: Biology of the Laboratory Mouse (E. L. Green, ed.), 2nd Ed., p. 1, McGraw-Hill, New York (1966).

    Google Scholar 

  3. J. J. Bittner, Tumor incidence in reciprocal F1 hybrid mice: A × D high tumor stocks, Proc. Soc. Exp. Biol. Med 34, 42–44 (1936).

    Article  Google Scholar 

  4. J.J. Bittner, Some possible effects of nursing on the mammary gland tumor incidence in mice, Science 84, 162–166 (1936).

    Article  PubMed  CAS  Google Scholar 

  5. R. A. Huseby and J. J. Bittner, Studies on the inherited hormonal influence, Acta Unio Int. Contra Cancrum 6, 197–205 (1948).

    Google Scholar 

  6. L. T. Samuels and J. J. Bittner, Excretion of steroids in the feces of mice of various strains with and without the mammary tumor milk agent, 38th Annual Meeting of the American Association of Cancer Research (1947) (abstract).

    Google Scholar 

  7. R. A. Huseby, Personal communication, August 27 (1977).

    Google Scholar 

  8. B. Zondek, Tumor of pituitary induced with follicular hormone, Lancet 1 (April 4), 776–778 (1936).

    Article  Google Scholar 

  9. C. J. Shellabarger, in: Biology of Radiation Carcinogenesis (J. M. Yuhas, R. W. Pennant, and J. D. Reagan, eds.), pp. 31–43, Raven Press, New York (1976).

    Google Scholar 

  10. C. Huggins, L. C. Grand, and F. P. Brillantes, Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression, Nature (London) 189, 204–207 (1961).

    Article  CAS  Google Scholar 

  11. A. C. Andersen, Parameters of mammary gland tumors in aging beagles, J. Am. Vet. Med. Assoc 147, 1653–1654 (1965).

    Google Scholar 

  12. R. Tyslowitz and E. Dingemanse, Effect of large doses of estrogens on the blood picture of dogs, Endocrinology 29, 817–827 (1941).

    Article  CAS  Google Scholar 

  13. R. Hill and K. Dumas, The use of dogs for studies of toxicity of contraceptive hormones, in: Pharmacological Models in Contraceptive Developments, p. 74, World Health Organization, Stockholm (1974).

    Google Scholar 

  14. V. A. Drill, D. P. Martin, and E. R. Hart, Effect of oral contraceptives on the mammary glands of rhesus monkeys: A preliminary report, J. Natl. Cancer Inst 52, 1655–1657 (1974).

    PubMed  CAS  Google Scholar 

  15. R. L. Kirschstein, A. S. Rabson, and G. W. Rusten, Infiltrating duct carcinoma of the mammary gland of a rhesus monkey after administration of an oral contraceptive: A preliminary report, J. Natl. Cancer Inst 48, 551–556 (1972).

    PubMed  CAS  Google Scholar 

  16. R. Hoover, L. A. Gray, Sr, P. Cole, et al., Menopausal estrogens and breast cancer, New Engl. J. Med 295, 401–405 (1976).

    Article  PubMed  CAS  Google Scholar 

  17. E. M. Glenn, S. L. Richardson, and B. J. Bowman, A method of assay of antitumor activity using a rat mammary fibroadenoma, Endocrinology 64, 379–389 (1959).

    Article  PubMed  CAS  Google Scholar 

  18. W. O. Nelson, The induction of mammary carcinoma in the rat, Yale J. Biol. Med 17, 217–228 (1944).

    PubMed  CAS  PubMed Central  Google Scholar 

  19. C. S. McEuen, Occurrence of cancer in rats treated with oestrone, Am J. Cancer 34, 184–195 (1938).

    PubMed  CAS  Google Scholar 

  20. C.F. Geschicter, Diseases of the Breast, J. B. Lippincott, Philadelphia (1943).

    Google Scholar 

  21. R. L. Noble, C. S. McEuen, and J. B. Collip, Mammary tumours produced in rats by the action of oestrone tablets, Can. Med. Assoc. J 42, 413–417 (1940).

    PubMed  CAS  PubMed Central  Google Scholar 

  22. R. L. Noble, A new approach to the hormonal cause and control of experimental carcinomas including those of the breast, Ann. R. Coll. Physicians Surg. Can 9, 169–180 (1976).

    Google Scholar 

  23. A. Segaloff and H. Pettigrew, Effect of radiation dosage on the synergism between radiation and estrogen in the production of mammary cancer in the rat Cancer Res (in press).

    Google Scholar 

  24. A. Segaloff, Inhibition by progesterone of radiation-estrogen-induced mammary cancer in the rat, Cancer Res 33, 1136–1137 (1973).

    PubMed  CAS  Google Scholar 

  25. J. H. Cutts, Estrogen-induced breast cancer in the rat, Sixth Canadian Cancer Conference, London (1966), p. 50.

    Google Scholar 

  26. F. Schiotzhe and J. K. McDonald, Relaxin: A disulfide homolog of insulin, Science 197, 914–915 (1977).

    Article  Google Scholar 

  27. E. M. O’Byrne and B. G. Steinetz, Radioimmunoassay (RIA) of relaxin in sera of various species using an antiserum to porcine relaxin, Proc. Soc. Exp. Biol. Med 152, 272–276 (1976).

    Article  PubMed  Google Scholar 

  28. E. M. O’Byrne, B. T. Carriere, L. Sorensen, A. Segaloff, C. Schwabe, and B. G. Steinetz, Plasma immunoreactive relaxin levels in pregnant and non-pregnant women, J. Clin. Endocrinol. Metab (in press) (1978).

    Google Scholar 

  29. J. H. Clark, Z. Paszko, and E. J. Peck Jr., Nuclear binding and retention of the receptor estrogen complex: Relation to the agonistic and antagonistic properties of estriol, Endocrinology 100, 91–96 (1977).

    Article  PubMed  CAS  Google Scholar 

  30. B. G. Miller, The relative potencies of oestriol, oestradiol and oestrone on the uterus and vagina of the mouse, J. Endocrinol 43, 563–570 (1969).

    Article  PubMed  CAS  Google Scholar 

  31. C. W. Emmens and L. Martin, Estrogens, in: Methods in Hormone Research (R. I. Dorfman, ed.), Vol. 3, pp. 1–80, Academic Press, New York (1964).

    Google Scholar 

  32. R. L. Noble, Hormonal control of growth and progression in tumors of Nb rats and a theory of action, Cancer Res 37, 82–94 (1977).

    PubMed  CAS  Google Scholar 

  33. G. V. Rudali, F. Apiou, and B. Muel, Mammary cancer produced in mice with estriol, Eur. J. Cancer 11, 39–41 (1975).

    Article  PubMed  CAS  Google Scholar 

  34. H. A. Bern, The neonatal mouse—Tumorigenesis after short-term exposure to hormones and its possible relevance to human syndrome, in: Proceedings: Symposium on Endocrine-Induced Neoplasia, Eppley Institute for Research in Cancer, Omaha, Nebraska (1977).

    Google Scholar 

  35. A. Lipschutz, Steroid Hormones and Tumors, Williams and Wilkins, Baltimore (1950).

    Google Scholar 

  36. W. O. Nelson, Endometrial and myometrial changes, including fibromyomatous nodules, induced in the uterus of the guinea pig by the prolonged administration of oestrogenic hormone, Anat. Rec 68, 99–102 (1937).

    Article  CAS  Google Scholar 

  37. G. W. Beatson, On the treatment of inoperable cases of carcinoma of the mammary gland: Suggestions for a new method of treatment with illustrative cases, Lancet 2, 104, 162 (1896).

    Article  Google Scholar 

  38. R. M. O’Bryan, G. S. Gordan, R. M. Kelley, R. G. Ravdin, A. Segaloff, and S. Taylor, Does thyroid substance improve response of breast cancer to surgical castration?, Cancer 33, 1082–1085 (1974).

    Article  PubMed  Google Scholar 

  39. C. C. Kapdi and J. N. Wolfe, Breast cancer: Relationship to thyroid supplements for hypothyroidism, J. Am. Med. Assoc 236, 1124–1127 (1976).

    Article  CAS  Google Scholar 

  40. I. Mittra and J. L. Hayward, Hypothalamic-pituitary-thyroid axis in breast cancer, Lancet 1 (May 11), 885–889 (1974).

    Article  PubMed  CAS  Google Scholar 

  41. P. Mustacchi and F. Greenspan, Thyroid supplementation for hypothyroidism: An iatrogenic cause of breast cancer?, J. Am. Med. Assoc 237, 1446–1447 (1977).

    Article  CAS  Google Scholar 

  42. American Thyroid Association, Breast cancer and thyroid therapy, J. Am. Med. Assoc 237, 1459–1460 (1977).

    Article  Google Scholar 

  43. J. Fishman, L. Hellman, B. Zumoff, and T. F. Gallagher, Influence of thyroid hormone on estrogen metabolism in man, J. Clin. Endocrinol. Metab 22, 389–392 (1962).

    Article  PubMed  CAS  Google Scholar 

  44. J. Fishman, L. Hellman, B. Zumoff, and T. F. Gallagher, Effect of thyroid on hydroxy-lation of estrogen in man, J. Clin. Endocrinol. Metab 25, 365–368 (1965).

    Article  PubMed  CAS  Google Scholar 

  45. J. Fishman, R. M. Boyar, and L. Hellman, Influence of body weight on estradiol metabolism in young women, J. Clin. Endocrinol. Metab 41, 989–991 (1975).

    Article  PubMed  CAS  Google Scholar 

  46. A. Segaloff, The “sparing’’ effect of progesterone on the hepatic inactivation of alpha-estradiol, Endocrinology 40, 44–46 (1947).

    Article  PubMed  CAS  Google Scholar 

  47. N. D. Cohen and R. Hilf, Influence of insulin on growth and metabolism of 7,12-dimethylbenz(a)anthracene induced mammary tumors, Cancer Res 34, 3245–3252 (1974).

    PubMed  CAS  Google Scholar 

  48. B. M. Sherman and S. S. Korenman, Hormonal characteristics of the human menstrual cycle throughout reproductive life, J. Clin. Invest 55, 699–702 (1975).

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  49. M. Kodama, T. Kodama, S. Miura, and M. Yoshida, Hormonal status of breast cancer. III. Further analysis of ovarian, adrenal dysfunction, J. Natl. Cancer Inst 59, 49–54 (1977).

    PubMed  CAS  Google Scholar 

  50. H. D. Moon, M. E. Simpson, C. H. Li, and H. M. Evans, Neoplasms in rats treated with pituitary growth hormone. III. Reproductive organs, Cancer Res 10, 549–556 (1950).

    PubMed  CAS  Google Scholar 

  51. J. Meites, Relation of prolactin to mammary tumorigenesis and growth in rats, in: Tenovus Workshop, Fourth, Cardiff, Wales, Prolactin and Carcinogenesis (A. R. Boyns and K. Griffiths, eds.), pp. 54–63, Alpha Omega Alpha, Cardiff, Wales (1972).

    Google Scholar 

  52. J. Furth, The influence of hormones on initiation and the maintenance of tumorous growths by radiation and other carcinogens, in: Symposium on Tumorigenic and Genetic Effects of Radiation (G. Woalinder, ed.), pp. 57–106, National Swedish Environment Protection Board, Solna (1976).

    Google Scholar 

  53. K. Yokoro and J. Furth, Relation of mammotropes to mammary tumors. V. Role of mammotropes in radiation carcinogenesis, Proc. Soc. Exp. Biol. Med 107, 921–924 (1961).

    Article  PubMed  CAS  Google Scholar 

  54. K. H. Clifton, B. N. Sridharan, and E. B. Dupole, Mammary carcinogenesis-enhancing effect of adrenalectomy in irradiated rats with pituitary tumor MtT-F 4, J. Natl. Cancer Inst 55, 485–487 (1975).

    PubMed  CAS  Google Scholar 

  55. K. H. Clifton, E. B. Dupole, and B. N. Sridharan, Effects of graft of single anterior pituitary gland on the incidence and type of mammary neoplasm in neutron or gamma irradiated Fischer female rats, Cancer Res 36, 3732–3735 (1976).

    PubMed  CAS  Google Scholar 

  56. R. D. Bulbrook, D. Y. Wang, and M. C. Swain, Prolactin and breast cancer, in: Tenovus Workshop, Fourth, Cardiff, Wales, Prolactin and Carcinogenesis (A. R. Boyns and K. Griffiths, eds.), pp. 143–148, Alpha Omega Alpha, Cardiff, Wales (1972).

    Google Scholar 

  57. C. W. Welsch and H. Nagasawa, Prolactin and murine mammary tumorigenesis: A review, Cancer Res 37, 951–963 (1977).

    PubMed  CAS  Google Scholar 

  58. Po-Chueu Chan, J. F. Head, L. A. Cohen, and E. L. Wynder, Effect of high fat diet on serum prolactin levels and mammary cancer development in ovariectomized rats, 68th Annual Meeting of the American Association of Cancer Research, May (1977) (abstract #753).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer Science+Business Media New York

About this chapter

Cite this chapter

Segaloff, A. (1978). Hormones and Mammary Carcinogenesis. In: McGuire, W.L. (eds) Breast Cancer:Advances in Research and Treatment, Vol. 2: Experimental Biology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-4673-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4673-0_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-4675-4

  • Online ISBN: 978-1-4757-4673-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics